Mesa LaboratoriesMLAB +3.92%77 Days Payable is 21.59 as of Mar. 2026, which is 8% below its 10-year median of 23.35. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.05 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 2,437 Hardware companies, Mesa Laboratories ranks worse than 92.65% on this metric.
The historical rank and industry rank for Mesa Laboratories's Days Payable or its related term are showing as below:
MLAB'
s Days Payable Range Over the Past 10 Years
Min: 19.97 Med: 23.35 Max: 30.65
Current: 21.92
During the past 13 years, Mesa Laboratories's highest Days Payable was 30.65. The lowest was 19.97. And the median was 23.35.
MLAB's Days Payable is ranked worse than 92.65% of 2437
companies
in the Hardware industry
Industry Median: 69.93
vs MLAB: 21.92
Mesa Laboratories's Days Payable
increased
from Mar. 2025 (18.91) to Mar. 2026 (21.59).
It may suggest that Mesa Laboratoriesdelayed paying its suppliers.
Mesa Laboratories Days Payable Related Terms
Mesa Laboratories Days Payable Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Days Payable vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Mesa Laboratories's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Days Payable of 21.59 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mesa Laboratories and its competitors. This is near median its historical median of 23.35. Over the past decade, Mesa Laboratories' Days Payable has ranged from 19.97 to 30.65. According to the industry distribution chart, Mesa Laboratories ranks #2258 out of 2437 companies in the Hardware industry, placing it in the top 92.7%.
Is Mesa Laboratories' Days Payable too high?
Mesa Laboratories' current Days Payable of 21.59 is near median its 10-year median of 23.35. Over the past 10 years, this metric has ranged from a low of 19.97 to a high of 30.65. The Hardware industry median Days Payable is 69.93. Mesa Laboratories' value of 21.59 is 69.1% below this industry median. Based on the distribution chart, Mesa Laboratories ranks #2258 out of 2437 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Days Payable compare to AERG and MVIS?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #2258 out of 2437 companies for Days Payable. This places Mesa Laboratories in the lower half of its industry. The industry median Days Payable is 69.93. Mesa Laboratories' value of 21.59 is 69.1% below this benchmark. Historically, Mesa Laboratories' own Days Payable has ranged from 19.97 to 30.65 over the past decade. While the company's 10-year median is 23.35 vs. the industry median of 69.93, Mesa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Hardware company?
The median Days Payable among Hardware companies is 69.93, based on 2,437 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Days Payable of 21.59 is 69.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Days Payable is 69.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Days Payable is 21.59, which is near median its own 10-year median of 23.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $98.18 — trading 15.4% below its estimated fair value. The current Days Payable is 21.59, which is near median its 10-year median of 23.35 and 69.1% below the Hardware industry median of 69.93. Mesa Laboratories' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Days Payable is 21.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $98.18 is trading 15.4% below its estimated GF Value™ of $116.05.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
Days Payable: 21.59 (near median its 10-year median of 23.35)
GF Value™: $116.05 vs. price of $98.18 (15.4% below fair value)
Industry Position: 69.1% below the Hardware median (#2258 of 2437)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
